Related references
Note: Only part of the references are listed.High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
Sara Correia Marques et al.
EXPERIMENTAL HEMATOLOGY (2016)
MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin
Dianzhong Geng et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate
Ying Tu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
Giuseppina Salzano et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Micelle-like Nanoparticles as Carriers for DNA and siRNA
Gemma Navarro et al.
MOLECULAR PHARMACEUTICS (2015)
A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging
Yaping Wang et al.
THERANOSTICS (2015)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer
G. Salzano et al.
CANCER LETTERS (2014)
The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors
Can Sarisozen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
Nishant S. Gandhi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Vladimir P. Torchilin
NATURE REVIEWS DRUG DISCOVERY (2014)
Morphine Induces Redox-Based Changes in Global DNA Methylation and Retrotransposon Transcription by Inhibition of Excitatory Amino Acid Transporter Type 3-Mediated Cysteine Uptake
Malav Trivedi et al.
MOLECULAR PHARMACOLOGY (2014)
Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Peptides in Plasmid DNA and siRNA Delivery
Ana M. Cardoso et al.
MOLECULAR PHARMACEUTICS (2013)
Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety
Lin Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
Helge Siemens et al.
ONCOTARGET (2013)
Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor Targeting
Lin Zhu et al.
ACS NANO (2012)
The invasion mode of GH3 cells is conditioned by collagen subtype, and its efficiency depends on cell-cell adhesion
Erika Azorin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Survivin isoform Delta Ex3 regulates tumor spheroid formation
Magali Espinosa et al.
CANCER LETTERS (2012)
Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model
Federico Perche et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Do Cell-Penetrating Peptides Actually Penetrate Cellular Membranes?
Caroline Palm-Apergi et al.
MOLECULAR THERAPY (2012)
Transient Focal Membrane Deformation Induced by Arginine-rich Peptides Leads to Their Direct Penetration into Cells
Hisaaki Hirose et al.
MOLECULAR THERAPY (2012)
The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility
J. G. Lees et al.
ONCOGENE (2011)
Effective Stabilization and Delivery of siRNA: Reversible siRNA-Phospholipid Conjugate in Nanosized Mixed Polymeric Micelles
Tiziana Musacchio et al.
BIOCONJUGATE CHEMISTRY (2010)
3D collagen type I matrix inhibits the antimigratory effect of doxorubicin
Emilie Millerot-Serrurot et al.
CANCER CELL INTERNATIONAL (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy
Jiping Zha et al.
CLINICAL CANCER RESEARCH (2010)
Methylselenol, a Selenium Metabolite, Induces Cell Cycle Arrest in G1 Phase and Apoptosis via the Extracellular-Regulated Kinase 1/2 Pathway and Other Cancer Signaling Genes
Huawei Zeng et al.
JOURNAL OF NUTRITION (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
A. W. Tong et al.
CANCER GENE THERAPY (2008)
Small non-coding RNAs in animal development
Giovanni Stefani et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
RNAi, microRNAs, and human disease
Scott M. Hammond
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Survival signaling by Notch1: Mammalian target of rapamycin (mTOR)-dependent inhibition of p53
Sathish Kumar Mungamuri et al.
CANCER RESEARCH (2006)
Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy
D Khaitan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways
M Lehnhardt et al.
BMC CANCER (2005)
Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance
IA Davidovich et al.
CANCER LETTERS (2004)
The role of glutathione in cancer
GK Balendiran et al.
CELL BIOCHEMISTRY AND FUNCTION (2004)
TAT-liposomes: A novel intracellular drug carrier
VP Torchilin et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2003)
Compensation mechanism in tumor cell migration:: mesenchymal-amoeboid transition after blocking of pericellular proteolysis
K Wolf et al.
JOURNAL OF CELL BIOLOGY (2003)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Share Paper
